Abstract
It has been estimated that about 100 billion human beings have walked on the surface of the Earth. If this is correct, it is an intriguing thought that one in 25 of them is alive today. In spite of famine, floods, plagues and wars, enough of each generation have survived not only to replace those lost in natural or self-inflicted disasters but also to expand the species at a rate which creates risks almost infinitely greater than any that we will discuss this evening. Our numbers have increased, we live much longer and we have more time to indulge in one of our favourite obsessions, which is concern about risk.
A reprint of the Wolfson College Lecture, Oxford, 31 January 1984. Reprinted by kind permission of Oxford University Press
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Office of Population Censuses and Surveys (1983). Mortality Statistics, England and Wales 1981. ( London: HMSO )
Urquhart, J and Heilmann, K Risk Watch. Understanding Risks in a Technological Society. (In press)
Inman, WHW (1981). Post-marketing surveillance. In Cavella, JF (ed.) Risk-Benefit Analysis in Drug Research, p. 141–61 ( Lancaster: MTP Press )
Rothschild (1978). The Listener. 30 November
Committee on Safety of Medicines (1982)
Second Benoxaprofen Symposium. 15th International Rheumatology Congress. Paris, June 1981. Europ J Rheumatol Inflamm (1982) 5 (2) 49–282
Inman, WHW (1977). Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphen- butazone. Br Med J, 1, 1500–5
Heilmann, K and Urquhart, J (1983). Keine Angst vor der Angst. ( Munich: Kindler Verlag )
Inman, WHW (1980). (ed.). Monitoring for Drug Safety. ( Lancaster: MTP Press )
Inman, WHW (1981). Post-marketing surveillance of adverse drug reactions in general practice. I: Search for new methods. Br Med J, 282, 1131–2
Inman, WHW (1981). Post-marketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J, 282, 1216–7
Inman, WHW and Vessey, MP (1968). Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. Br Med J, 2, 193–9
Inman, WHW, Vessey, MP, Westerholm, B and Engelund, A (1970). Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Medicines. Br Med J, 2, 203–9
Finney, DJ (1965). The design and logic of a monitor of drug use. J Chron Dis, 18, 77–98
Drug Surveillance Research Unit (1983). PEM News, No. 1, ( Southampton: Hamble Valley Press )
Hook, BG, Rumson, JL, Jolly SR, Bailie, MB and Lucchesi, BR (1983). Effect of Zomepirac on experimental coronary artery thrombosis and ischaemic myocardial injury in the con scious dog. J Cardiovasc Pharmacol, 5, 302–8
Lewis, HD et al. (1983). Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med, 309 (7), 396–403
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 MTP Press Limited
About this chapter
Cite this chapter
Inman, W.H.W. (1986). Risks in Medical Intervention: Balancing Therapeutic Risks and Benefits. In: Worden, A.N., Parke, D.V., Marks, J. (eds) The Future of Predictive Safety Evaluation. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4139-7_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-4139-7_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8336-2
Online ISBN: 978-94-009-4139-7
eBook Packages: Springer Book Archive